Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Ricky K Hsu, MD, PC, New York

Orlando Immunology Center, Orlando

Central West Clinical Research, Inc., St Louis

Gordon Crofoot, MD, PA, Houston

Southwest CARE Center, Santa Fe

UCLA Center for AIDS Research and Education, Los Angeles

Orange Coast Medical Group, Newport Beach

Quest Clinical Research, San Francisco

Circle CARE Center, LLC, Norwalk